Many foreign compounds, including drugs and chemical carcinogens, are oxidized by liver microsomes of all animal species studied so far (Conney, 1967) . Several transplantable rat tumours such as Morris hepatomas 5123C, 5123D and 7800 have been described as minimal deviation or well-differentiated hepatomas because they have many morphological and biochemical characteristics closely resembling normal liver; these hepatomas were initially produced by oral administration of various fluorene derivatives (Morris, 1965) . These, as well as poorly differentiated and primary liver tumours, have low or negligible enzyme activity to oxidize foreign compounds (Conney, Brown, Miller & Miller, 1957; Neubert & Hoffmeister, 1960; Adamson & Fouts, 1961; Conney & Burns, 1963; Hart, Adamson, Morris & Fouts, 1965; Roger, Morris & Fouts, 1967) . Conney & Burns (1963) have shown that hepatoma 5123C had low azo-dye N-demethylase enzyme activity and that this activity could be stimulated by administration of MC.* Phenobarbital pretreatment of tumour-bearing animals has also been shown to induce drug-* Abbreviations: MC, 3-methylcholanthrene; AAF, 2-acetamidofluorene; x-hydroxy-AAF, 2-acetamido-xhydroxyfluorene; 3'-methyl-DAB, 4-dimethylamino-3'-methylazobenzene. metabolizing enzyme activities in several liver tumours (Hart et al. 1965; Roger et al. 1967) .
N-Hydroxylation of AAF was first reported by Cramer, Miller & Miller (1960b) . They showed that N-hydroxy-AAF appeared in the rat urine as a conjugate (probably the glucuronide) and was found in increasing amounts as the feeding of the carcinogen progressed. The potent carcinogen AAF is metabolized by rat liver microsomes, not only to various non-carcinogenic ring-hydroxylated products, namely 1-, 3-, 5-and 7-hydroxy-AAF (Booth & Boyland, 1957; Seal & Gutmann, 1959; Cramer, Miller & Miller, 1960a) , but also to more carcinogenic N-hydroxy derivatives (Irving, 1964; Lotlikar, Enomoto, Miller & Miller, 1967) . Administration of MC with AAF inhibits the carcinogenicity of AAF in the rat (Miyaji et al. 1953; Miller, Miller, Brown & MacDonald, 1958) . Pretreatment of rats with MC also causes a decreased urinary excretion of N-hydroxy-AAF (Miller, Cramer & Miller, 1960; Lotlikar et al. 1967) . However, in studies in vitro with rat liver microsomes, both ring and N-hydroxylation of AAF are increased severalfold when MC is administered to animals 24h before they are killed (Cramer et al. 1960a; Lotlikar et al. 1967) . On the other hand, after pretreatment ofhamsters with MC, there is a specific and relatively large increase only in N-hydroxylation by their liver microsomes (Lotlikar et al. 1967) . From carbon monoxide inhibition studies it has been suggested that cytochrome P-450 is involved in ring hydroxylation and not in N-hydroxylation of aromatic amines (Kampffmeyer & Kiese, 1965; Hlavica & Kiese, 1969) .
The purpose of the present work was to determine the N-and ring hydroxylation of AAF by microsomal preparations of various transplantable and primary hepatomas and their host livers with and without MC pretreatment of tumour-bearing animals. by Poirier, Miller & Miller (1963) . NADH, NADPH and ATP were obtained from Sigma Chemical Co., St Louis, Mo., U.S.A. All other chemicals were of reagent grade.
MATERIALS AND METHODS
Injection of MC. Animals were injected intraperitoneally with MC (10mg/1OOg body wt.) suspended in olive oil (1Omg/ml) 24h before they were killed. Animals bearing primary tumours with 3'-methyl-DAB were fed on regular commercial diet for a week before MC injection. Control animals were injected with olive oil.
Preparation of micro8Omes. After the animals were decapitated, the tissues were immediately removed and chilled in ice-cold 0,25M-sucrose solution. Tumours were then quickly freed from surrounding tissues and from necrotic material, if any. A 10% (w/v) homogenate of tissue prepared in 0.25M-sucrose solution was centrifuged at 80OOg for 10min to remove nuclei and mitochondria. The microsomal pellet was obtained by centrifuging the mitochondrial supernatant at 1050OOg for 60min. The surface of the microsomal pellet was washed twice with 0.25 M-sucrose before it was resuspended in the same medium.
Assay for ring and N-hydroxylation of AAF. The incubation medium contained lOO,umol of potassium phosphate buffer, pH7.8, 400,umol of KCI, 240,umol of nicotinamide, 600,umol of KF, 4,umol of ATP, 1.06,umol of NADPH, 1.22 umol of NADH, 0.45,tmol of AAF added in 0.2ml of methanol, tissue microsomes equivalent to 60mg wet wt. of tissue, 150,tmol of sucrose and water to a final volume of 6.Oml. This incubation medium is almost identical with that described by Cramer et al. (1960a) for ring hydroxylation of AAF except for the addition of KF. The presence of 0.1 m-KF in the incubation system inhibits deacetylase activity (Seal & Gutmann, 1959; Irving, 1964; Lotlikar, Miller, Miller & Margreth, 1965) . The flasks were incubated in air for 20min at 37°C, after which 8ml of ice-cold-lM-sodium acetate buffer, pH 6.0, was added per flask. Contents of 18 flasks were combined for each analysis and extracted immediately with diethyl ether. The acidic metabolites were extracted from the ether extract into 0.5M-NaOH; finally the alkali extract was neutralized to pH 6.0 and the metabolites were extracted in diethyl ether. The acidic metabolites were chromatographed on. Whatman no. 1 paper with cyclohexane-2-methylpropan-2-ol-acetic acid-water (16 :4:2:1, by vol.) (Weisburger, Weisburger, Morris & Sober, 1956 ). After chromatography the strips were air-dried and then viewed under u.v. light. Appropriate absorption zones were cut out and eluted overnight in 3ml of 95% (v/v) ethanol. The metabolites were determined quantitatively by u.v. absorption in the range 350-270nm by using a Hitachi-Coleman recording spectrophotometer. The following molar extinction coefficients with maximum wavelengths in parentheses were used for authentic hydroxy compounds of AAF: N-hydroxy-AAF, 23400 (287nm); 3-hydroxy-AAF, 17400 (315nm); 5-hydroxy-AAF, 25500 (283nm); 7-hydroxy-AAF, 29800 (291nm). Before spectral analysis, the N-hydroxy-AAF was separ. ated from AAF by extraction with 0.5m-NaOH. All of the results presented were corrected by the following recovery data: N-hydroxy-AAF, 75%; 3-hydroxy-AAF, 70%; 5-hydroxy-AAF, 90%; 7-hydroxy-AAF, 63%. The amounts of 1-hydroxy-AAF were generally too low to measure adequately and the values for this metabolite have therefore been omitted. Wherever values of 10 or less nmol/20min per g wet wt. of tissue are given for any metabolite, it indicates that a small amount of u.v.-lightabsorbing material with a non-characteristic spectrum was eluted.
RESULTS
Rates of both N-and ring hydroxylation of AAF by liver and kidney microsomes from normal rats with and without MC pretreatment are presented in Table 1 . The liver of untreated control animals has much greater hydroxylating activity than has (Lotlikar et al. 1967) . Activity in the kidney of treated animals showed severalfold increase in ring hydroxylation without affecting concentrations of N-hydroxy-AAF. The enzyme activities in kidney after MC stimulation were much less than in liver. Wattenberg & Leong (1962) and Gelboin & Blackburn (1964) have also reported increases in benzpyrene hydroxylase in kidney extracts after MC pretreatment of animals.
The activities of various well-differentiated hepatomas and their host livers are summarized in Table 2 . Tumour tissues and livers of all untreated tumour-bearingratshadlowhydroxylatingactivity; activity of the livers was higher than that of tumours. Pretreatment with MC caused several-fold increase in both N-and ring hydroxylation in the host livers, whereas in tumours except 5123CTC it caused a many-fold increase in ring hydroxylation only. Tumour 5123CTC showed a fourfold increase in N-hydroxylation activity also. Kidneys of the tumour-bearing rats also responded to MC pretreatment, like kidneys of non-tumour-bearing rats (see Table 1 ).
The effects of MC administration on the rates of AAF hydroxylation by poorly differentiated rat hepatomas and their host livers are given in Table 4 . Effects of MCpretreatment on hydroxylation of AAF by primary tumour8 and the host ti8sues
The primary liver tumours were produced in adult male rats weighing 175-200g by administration of 0.06% 3'-methyl-DAB for 17 weeks as described by Shatton etal. (1962) . These animals were fed on regular commerical diet for a week before MC injection. The primary mammary tumours were produced in adult Sprague-Dawleystrain female rats by oral administration of 10mg of MC/day for 20 days. All other details are described in the Materials and Methods Section. Values are given as means±s.E.M. of three determinations.
Hydroxylation host livers ofNovikoff or well-differentiated-tumour bearing rats (see Table 1 ). puromycin or actinomycin D with either MC or phenobarbital prevents the stimulation of microsomal oxidative enzymes Conney, Davison, Gastel & Burns, 1960; Gelboin & Blackburn, 1964; Lotlikar et al. 1967 ). These and amino acid-incorporation studies (Gelboin & Blackburn, 1963) indicate that MC, phenobarbital and several other inducers (Conney, 1967) cause induction or synthesis of new microsomal enzyme proteins. It has been shown that several well-differentiated tumours, namely Morris hepatomas 5123C, 5123D and 7800, have either little or no ability to metabolize various drugs (Conney & Burns, 1963; Hart et al. 1965; Lotlikar et al. 1965; Roger et al. 1967 ). The present results are in agreement with these earlier findings. Pretreatment of animals with MC caused several-fold increase in the hydroxylating activities of tumours compared with the tumours of untreated animals. These stimulations are much more pronounced than those observed with phenobarbital treatment (Hart et al. 1965; Roger et al. 1967) . In the present experiments only one tumour, Morris hepatoma 5123CTC, could Nhydroxylate AAF when tumour-bearing animals were pretreated with MC. This appears to be the first example of N-hydroxylation of AAF by any tumour tissue studied so far. The present results suggest that the activities of oxidative enzymes are low or diminished in well-differentiated tumours, but that the enzyme activities can be increased in these tumours by certain inducers such as MC.
In contrast with well-differentiated hepatomas, poorly differentiated hepatomas could not be stimulated by MC pretreatment. Thus, in my experiments, both tumours 7288CTC and Novikoff were resistant to MC effect. Hart et al. (1965) observed that pretreatment of Novikoff-tumourbearing animals with phenobarbital did not have any effect on the metabolism of aminopyrine, neoprontosil or p-nitrobenzoic acid by a supernatant fraction from the Novikoff hepatoma. They reported, however, that the side-chain oxidation of hexobarbital was stimulated in this tumour to a slight but statistically significant extent. It appears that various substrates have different affinities for the oxidative enzymes. In the present studies, host liver of 7288CTC-tumour-bearing animals had high N-and ring-hydroxylating activity before MC pretreatment. Administration of MC increased the activity about twofold. One possible explanation for the high activity in the host liver before MC pretreatment could be that the tumour might have acted as an inducer for the host liver.
